Page last updated: 2024-09-04

lexapro and telmisartan

lexapro has been researched along with telmisartan in 1 studies

Compound Research Comparison

Studies
(lexapro)
Trials
(lexapro)
Recent Studies (post-2010)
(lexapro)
Studies
(telmisartan)
Trials
(telmisartan)
Recent Studies (post-2010) (telmisartan)
170121,9304801,038

Protein Interaction Comparison

ProteinTaxonomylexapro (IC50)telmisartan (IC50)
Cytochrome P450 2C9 Homo sapiens (human)0.42
Type-1 angiotensin II receptorHomo sapiens (human)0.0179
Type-2 angiotensin II receptorHomo sapiens (human)0.0003
Cytochrome P450 2J2Homo sapiens (human)0.5
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.2589
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.8621

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

1 other study(ies) available for lexapro and telmisartan

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013